Article
CircTADA2A stabilizes p53 via interacting with TRIM28 and suppresses the maintenance of FLT3-ITD acute myeloid leukemia.
Leukemia - 1 Jun 2025
Li Ran, Wu Xiaolu, Xue Kai, Wu Shishuang, Jiang Ge, He Mengke, Xia Yi, Liu Hailing, Zhong Miao, Li Jianyong, Fan Lei, Li Junmin
Abstract excerpt
Internal tandem duplication mutations in the FMS-like tyrosine kinase 3 (FLT3-ITDs) occur in 25%-30% of acute myeloid leukemia (AML) cases and are associated with adverse prognosis. RNA-based therapeutics exhibit significant potential for treating diseases, prompting us to develop a novel circular RNA (circRNA)-based therapeutic strategy for FLT3-ITD AML. Here, we find circTADA2A is downregulated in FLT3-ITD AML...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
